RT Journal Article
SR Electronic
T1 Dysregulation of the Kennedy Pathway and Tricarboxylic Acid Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.14.21258895
DO 10.1101/2021.06.14.21258895
A1 Che, Xiaoyu
A1 Brydges, Christopher R.
A1 Yu, Yuanzhi
A1 Price, Adam
A1 Joshi, Shreyas
A1 Roy, Ayan
A1 Lee, Bohyun
A1 Barupal, Dinesh K.
A1 Cheng, Aaron
A1 Palmer, Dana March
A1 Levine, Susan
A1 Peterson, Daniel L.
A1 Vernon, Suzanne D.
A1 Bateman, Lucinda
A1 Hornig, Mady
A1 Montoya, Jose G.
A1 Komaroff, Anthony L.
A1 Fiehn, Oliver
A1 Lipkin, W. Ian
YR 2021
UL http://medrxiv.org/content/early/2021/06/22/2021.06.14.21258895.abstract
AB Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and debilitating disease that is characterized by unexplained physical fatigue unrelieved by rest. Symptoms also include cognitive and sensory dysfunction, sleeping disturbances, orthostatic intolerance and gastrointestinal problems. The pathogenesis is not fully understood. Using regression, Bayesian and enrichment analyses, we conducted targeted and untargeted metabolomic analysis of 888 metabolic analytes in plasma samples of 106 ME/CFS cases and 91 frequency-matched healthy controls. In ME/CFS cases, the regression, Bayesian and enrichment analyses all revealed abnormal levels of several membrane lipids indicating dysregulation of the Kennedy pathway: decreased plasma levels of plasmalogens, phosphatidylcholines, phosphatidylethanolamines, sphingomyelins, and phospholipid ethers. Enrichment analyses revealed decreased levels of cholines, ceramides and carnitines, and increased levels of long chain triglycerides, dicarboxylic acids, hydroxy-eicosapentaenoic acid, and the tricarboxylic acid cycle intermediates alpha-ketoglutarate and succinate. Using machine learning algorithms with selected metabolites as predictors, we were able to differentiate female ME/CFS cases from female controls (highest AUC=0.794) and ME/CFS cases without self-reported irritable bowel syndrome (sr-IBS) from controls without sr-IBS (highest AUC=0.873). Our findings are consistent with earlier ME/CFS work indicating compromised energy metabolism and redox imbalance, and highlight specific abnormalities that may provide insights into the pathogenesis of ME/CFS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Institutes of Health U54 AI138370 (Center for Solutions for ME/CFS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Columbia University Irving Medical Center (CUIMC) Institutional Review Board. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be uploaded upon acceptance into a peer-reviewed journal.